-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

711. Cell Collection and Processing: Poster III

Cell Collection and Processing Program: Oral and Poster Abstracts
Type: Poster
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Mateusz Adamiak, MS1*, Ahmed Abdel-Latif, MD, PhD2*, Janina Ratajczak, MD, PhD3 and Mariusz Z Ratajczak, MD, PhD1

1Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY
2Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY
3Stem Cell Institute, James Graham Brown Cancer Center at University of Louisville, Louisville, KY

Meng Qin, PhD1,2*, Xin Guan, B.S.2*, Yu Zhang, B.S.2*, Qing-yu Zhang, PhD3*, Wei Dai, PhD4*, Yupo Ma, MD, PhD5 and Yongping Jiang, PhD2

1Biopharmagen corp, Suzhou, China
2Biopharmaceutical R&D Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, China
3School of Public Health, University at Albany, Albany, NY
4Environmental Medicine, NYU Langone Medical Center, Tuxedo, NY
5Department of Pathology, Stony Brook University, Stony Brook, NY

Juliana Montibeller Silva, MD1*, Kanchan Rao, MNAMS (Paed), MRCP (Paed)1*, Robert Chiesa2*, Stuart Adams, PHD3*, Margaret Brocklesby4*, Gulrukh Ahsan4*, Giovanna Lucchini5*, Paul Veys5*, Persis Jal Amrolia5* and Nicholas Goulden, MD, PhD6

1Bone Marrow Transplant, Great Ormond Street Hospital, London, United Kingdom
2Bone MarrowTransplant, GREAT ORMOND STREET HOSPITAL, London, United Kingdom
3GREAT ORMOND STREET HOSPITAL, London, United Kingdom
4Great Ormond Street Hospital, London, United Kingdom
5Bone Marrow Transplantation Department, Great Ormond Street Hospital, London, United Kingdom
6Department of Haematology, Great Ormond Street Hospital For Children, London, United Kingdom

Ryuji Tanosaki, MD, PhD1, Yoshiki Okuyama, M.D.2*, Tohru Iseki, MD, PhD3*, Makoto Handa4*, Shuichi Kino, M.D.5*, Katsuya Ikuta, MD, PhD6, Shigehisa Yoshida, M.T.7*, Kyoko Haraguchi, M.D.2*, Naomi Shimizu, MD8*, Shio Sakai, MD, PhD9*, Naohide Watanabe, MD, PhD10*, Tomoe Uemura, M.T.11*, Yoshie Kawahara, M.T.6*, Kazuo Muroi, M.D., Ph.D.12*, Tokiko Nagamura-Inoue, MD, PhD13 and Minoko Takanashi, MD, Ph.D14*

1Department of Blood Transfusion and Cellular Therapy, National Cancer Center Hospital, Tokyo, Japan
2Division of Transfusion and Cell Therapy, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
3Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan
4Center for Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan
5Hokkaido Block Blood Center, Japanese Red Cross Society, Hokkaido, Japan
6Asahikawa Medical University Hospital, Hokkaido, Japan
7National Cancer Center Hospital, Tokyo, Japan
8Department of Blood Transfusion, Toho University Medical Center Sakura Hospital, Chiba, Japan
9Division of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan
10Department of Transfusion Medicine and Cell Therapy, Keio University School of Medicine, Tokyo, Japan
11Center for Transfusion Medicine and Cell Therapy, Keio University, Tokyo, Japan
12Division of Cell Transplantation and Transfusion, Jichi Medical University, Tochigi, Japan
13Department of Cell Processing and Transfusion, The Institute of Medical Science, University of Tokyo, Tokyo, Japan
14Blood Service Headquarters, Japanese Red Cross, Tokyo, Japan

Giuseppe Milone, MD1, Massimo Martino2*, Annalia Di Marco, BS1*, Salvatore Leotta, MD1*, Andrea Spadaro, MD1*, Mara Morelli, MD,3*, Giuseppe Avola1*, Maria Grazia Camuglia1*, Alessandra Cupri, MD1*, Valentina Zammit, MD1*, Potito Rosario Scalzulli, MD4*, Calafiore Valeria, MD1*, Attilio Olivieri, MD5 and Giovanni Tripepi, PhD6*

1Hematology and BMT Unit, Azienda Policlinico Vittorio Emanuele, Catania, Italy
2Hematology and BMT Unit, Ospedale Bianco Melacrino Morelli, Reggio Calabria, Italy
3Hematology and BMT Unit, IRCCS San Raffaele, Milano, Italy
4Hematology and BMT Unit, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
5Haematology and BMT Unit, Ospedali Riuniti di Ancona-Università Politecnica delle Marche, Ancona, Italy
6Fisiologia Clinica, CNR, Pisa, Italy

Sara Matar, MD1*, Mohammed Dany1*, Saurabh Chhabra, MD1*, Luciano J Costa, MD, PhD2 and Robert K. Stuart, MD1

1Medical University of South Carolina, Charleston, SC
2Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

Christina Berens, MD1*, Annkristin Heine, MD2*, Jens Mueller, PhD1*, Johannes Oldenburg1, Dominik Wolf, MD2*, Bernd Poetzsch, Prof.1* and Heiko Ruehl, MD1*

1Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany
2Department of Internal Medicine III, Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany

Araci M. Sakashita, MD1*, Andrea Tiemi Kondo, MD1*, Ana Paula Hitomi Yokoyama, MD1*, Carolina Bonet Bub, MD1*, Sanny Marcele da Costa Lira, MD1*, Cristiane Yoshie Nakazawa, MD1*, Andrea Neri Folchini Cipolletta, RN1*, Nelson Hamerschlak, PhD2 and Jose M Kutner, MD, PhD1

1Hemotherapy and Cell Therapy Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
2Hematology/Oncology Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil

Kevin Shoulars, PhD1*, Tracy Gentry1*, Pamela Noldner1*, Kristin M Page, MD2* and Joanne Kurtzberg, MD3

1Duke University Medical Center, Durham, NC
2Division of Pediatric Blood and Marrow Transplant, Duke University Medical Center, Durham, NC
3CT2, DTMI, Duke University, Durham, NC

*signifies non-member of ASH